Cargando…

Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists

Background: Epidermal growth factor receptor (EGFR) inhibitors can cause serious cutaneous toxicities, including pruritus and papulopustular acneiform skin eruptions. Increasingly, the neurokinin-1 receptor (NK1R) antagonist aprepitant is being utilized as an anti-pruritic agent in the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwatra, Shawn G., Boozalis, Emily, Huang, Amy H., Nanni, Cory, Khanna, Raveena, Williams, Kyle A., Semenov, Yevgeniy R., Roberts, Callie M., Burns, Robert F., Krischak, Madison, Kwatra, Madan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963385/ https://www.ncbi.nlm.nih.gov/pubmed/31835310 http://dx.doi.org/10.3390/medicines6040114

Ejemplares similares

Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
por: Halik, Paweł K., et al.
Publicado: (2020)

The Potential In Vitro Inhibitory Effects of Neurokinin-1 Receptor (NK-1R) Antagonist, Aprepitant, in Osteosarcoma Cell Migration and Metastasis
por: Alsaeed, Mohammed Ali, et al.
Publicado: (2022)

Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV
por: Barrett, Jeffrey S., et al.
Publicado: (2016)

Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance
por: García-Aranda, Marilina, et al.
Publicado: (2022)

Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)

The NK-1R Antagonist Aprepitant Prevents LPS-Induced Oxidative Stress and Inflammation in RAW264.7 Macrophages
por: Zhao, Xiao-nan, et al.
Publicado: (2020)

Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
por: Ständer, Sonja, et al.
Publicado: (2010)

The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
por: Muñoz, Miguel, et al.
Publicado: (2020)

Affinity, potency, efficacy, and selectivity of neurokinin A analogs at human recombinant NK2 and NK1 receptors
por: Rupniak, Nadia M. J., et al.
Publicado: (2018)

Capsaicin-Mediated Neurogenic Vasodilatation in Neurokinin-1, NK(1), Receptor Knockout Mice
por: Grant, A. D., et al.
Publicado: (2001)

Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK(1)) receptor antagonists
por: Bošnjak, Snežana M., et al.
Publicado: (2017)

Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation
por: Jones, Sarah, et al.
Publicado: (2008)

Mirtazapine for the Treatment of Chronic Pruritus
por: Khanna, Raveena, et al.
Publicado: (2019)

Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor
por: Zheng, Yang, et al.
Publicado: (2023)

PreBötzinger complex (preBötC) neurokinin-1 receptor (NK1R) expressing neurons are required for eupnea in adult awake rats
por: Gray, PA, et al.
Publicado: (2001)

GPCR large-amplitude dynamics by (19)F-NMR of aprepitant bound to the neurokinin 1 receptor
por: Pan, Benxun, et al.
Publicado: (2022)

The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant
por: Coveñas, Rafael, et al.
Publicado: (2023)

Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage
por: Jin, Peng, et al.
Publicado: (2022)

Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting
por: Lim, Chae Seong, et al.
Publicado: (2013)

A lack of functional NK1 receptors explains most, but not all, abnormal behaviours of NK1R-/- mice1
por: Porter, A J, et al.
Publicado: (2015)

Establishing and functional characterization of an HEK-293 cell line expressing autofluorescently tagged β-actin (pEYFP-ACTIN) and the neurokinin type 1 receptor (NK1-R)
por: Hrovat, Alenka, et al.
Publicado: (2009)

LIF Upregulates Expression of NK-1R in NHBE Cells
por: Hu, Cheng-Ping, et al.
Publicado: (2006)

The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
por: Muñoz, Miguel, et al.
Publicado: (2020)

Identification of Human NK17/NK1 Cells
por: Pandya, Abhilash D., et al.
Publicado: (2011)

Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
por: Gadais, Charlène, et al.
Publicado: (2021)

Association between Itch and Cancer in 3836 Pediatric Pruritus Patients at a Tertiary Care Center
por: Belzberg, Micah, et al.
Publicado: (2019)

Association with FcRγ Is Essential for Activation Signal through NKR-P1 (CD161) in Natural Killer (NK) Cells and NK1.1(+) T Cells
por: Arase, Noriko, et al.
Publicado: (1997)

SP/NK‐1R promotes gallbladder cancer cell proliferation and migration
por: Deng, Xue‐Ting, et al.
Publicado: (2019)

Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity
por: Recio, Rocío, et al.
Publicado: (2021)

Diagnostic Workup and Evaluation of Patients with Prurigo Nodularis
por: Kwon, Christina D., et al.
Publicado: (2019)

P1426: WU-NK-101, AN ALLOGENEIC MEMORY NK CELL, FOR THE TREATMENT OF RELAPSE OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
por: Muth, J. J., et al.
Publicado: (2022)

Bone Marrow NK1.1(−) and NK1.1(+) T Cells Reciprocally Regulate Acute Graft versus Host Disease
por: Zeng, Defu, et al.
Publicado: (1999)

First Evaluation of [(11)C]R116301 as an In Vivo Tracer of NK1 Receptors in Man
por: Wolfensberger, Saskia P. A., et al.
Publicado: (2009)

The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders
por: Johnson, M. Brittany, et al.
Publicado: (2017)

Potential therapeutic effect of NK1R antagonist in diabetic non-healing wound and depression
por: Li, Mingyu, et al.
Publicado: (2023)

Neurokinin-1 (NK-1) receptor and brain-derived neurotrophic factor (BDNF) gene expression is differentially modulated in the rat spinal dorsal horn and hippocampus during inflammatory pain
por: Duric, Vanja, et al.
Publicado: (2007)

NK Cells and Type 1 Diabetes
por: Rodacki, Melanie, et al.
Publicado: (2006)

A Randomized, Placebo Controlled, Double Masked Phase IB Study Evaluating the Safety and Antiviral Activity of Aprepitant, a Neurokinin-1 Receptor Antagonist in HIV-1 Infected Adults
por: Tebas, Pablo, et al.
Publicado: (2011)

PD-1 expression on mouse intratumoral NK cells and its effects on NK cell phenotype
por: Wagner, Arnika K., et al.
Publicado: (2022)

Differences in the performance of NK1R−/− (‘knockout’) and wildtype mice in the 5‑Choice Continuous Performance Test
por: Porter, Ashley J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2kl2mnh64cb9saimsougb2ldt2